Key players operating in the global Guillain--Barre syndrome market are Grifols S.A., CSL Behring LLC, Shire plc, Octapharma AG, Nihon Pharmaceutical Co., Ltd., Akari Therapeutics, PLC, China Biologic Products Holdings, Inc.,
Biotest AG, and Kedrion s.p.A.
The companies that have been mentioned in the market report are Cerus Corp., General Electric, Co., China Biologic Products, Inc., ADMA Biologics, Inc., CSL Ltd.,
Biotest AG, Grifols International S.A., Baxter International, Inc., Octapharma AG, Arthrex and Shire Plc.
Medical Centers Diamed and Olainmed revenues were EUR 1.8 million during the first seven months of this year and the Belarus company NPK
Biotest sales were worth EUR 1.7 million, improving the result of the last year by 36 percent.
Key companies profiled in the report include Grifols S.A., CSL Behring LLC, Shire Plc.,
Biotest AG, Kedrion S.p.A., Octapharma AG, Baxalta Incorporated and Talecris Biotherapeutics, Inc.
M2 EQUITYBITES-April 30, 2019-Grifols to open new Georgia
Biotest plasma donor centre
M2 PHARMA-April 30, 2019-Grifols to open new Georgia
Biotest plasma donor centre
Spanish healthcare company Grifols disclosed on Friday the inauguration of its 15,000 square foot
Biotest plasma donor centre located at 1105 W Main Street, Russellville, Arkansas.
I take the following Global Formulas supplements: bioSupport, bioEndure, bioRepair, bioSleep, bioPUMPd, bioProZero,
bioTest, bioCarb, bioLean and bioHeat.
The EIR discusses many improvements and resolutions made by the Company to the majority of observations previously existing from the 2014 and 2016 FDA inspections of the Boca Raton, FL facility while owned and operated by
Biotest Pharmaceuticals.
(NYSE: CRL) has acquired UK-based contract research organisation KWS
BioTest, the company said.